Simultaneous measurement of 92 serum protein biomarkers for the development of a multiprotein classifier for ovarian cancer detection.

被引：0
|
作者：
Skubitz, Amy P. N. [1 ]
Boylan, Kristin L. M. [1 ]
Geschwind, Kate [1 ]
Cao, Qing [1 ]
Starr, Timothy K. [1 ]
Geller, Melissa A. [1 ]
Bast, Robert C., Jr. [2 ]
Lu, Karen H. [2 ]
Koopmeiners, Joseph S. [1 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Univ Texas Houston, Houston, TX USA
来源：
CLINICAL CANCER RESEARCH | 2018年 / 24卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B20
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [41] Simultaneous detection of ovarian cancer related miRNA biomarkers with carboxylated graphene oxide modified electrochemical biosensor platform
    Kivrak, Ezgi
    Kara, Pinar
    BIOELECTROCHEMISTRY, 2025, 161
  • [42] MicroRNA as biomarkers in early detection and personalized treatment in ovarian cancer: Development of a personalized prevention consortium
    Fortner, Renee Turzanski
    langseth, HilDe
    CANCER RESEARCH, 2024, 84 (05)
  • [43] Protein profiling to identify serum biomarkers for early detection of breast cancer in African American women
    Tadi-Uppala, Padma P.
    Blackledge, William
    Beeson, Larry
    Thadi, Pramila P.
    Garberoglio, Carlos
    Morgan, John
    Uppala, Gurunatha
    Lum, Sharon
    Kolli, Kumar Vs
    Kirchner, David
    Preuss, Alisha
    Mural, Richard
    Liebman, Michael
    Montgomery, Susanna
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Serum Autoantibodies against LRDD, STC1, and FOXA1 as Biomarkers in the Detection of Ovarian Cancer
    Duan, Yaru
    Cui, Chi
    Qiu, Cuipeng
    Sun, Guiying
    Wang, Xiao
    Wang, Peng
    Ye, Hua
    Dai, Liping
    Shi, Jianxiang
    DISEASE MARKERS, 2022, 2022
  • [45] Multiple Biomarker Simultaneous Detection in Serum via a Nanomaterial-Functionalized Biosensor for Ovarian Tumor/Cancer Diagnosis
    Wu, Yu
    Wang, Chunhua
    Wang, Chao
    Wang, Pan
    Chang, Xiaohan
    Han, Lin
    Zhang, Yu
    MICROMACHINES, 2022, 13 (12)
  • [46] Development of extracellular vesicles-based classifier for detection of early-stage bladder, ovarian, and pancreatic cancer.
    Hinestrosa, Juan Pablo
    Kurzrock, Razelle
    Lewis, Jean
    Schork, Nick
    Kamat, Ashish M.
    Lowy, Andrew M.
    Eskander, Ramez Nassef
    Perrera, Orlando
    Searson, David
    Clark, Iryna
    Balcer, Heath
    Adler, Mark J.
    Lippman, Scott Michael
    Krishnan, Rajaram
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Proteome using protein chips in serum and tear fluid: identification of biomarkers for early detection of breast cancer
    Boehm, D.
    Lebrecht, A.
    Keller, K.
    Schwirz, R.
    Schmidt, M.
    Grus, F.
    Koelbl, H.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 736 - 736
  • [48] Molecular epidemiological study on smoking-associate lung cancer: Detection and validation of protein biomarkers in serum
    Wang, Wenjing
    Lu, Wei
    Xiang, Cuiqin
    CANCER RESEARCH, 2006, 66 (08)
  • [49] Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers
    Tooker, Brian C.
    Newman, Lee S.
    Bowler, Russell P.
    Karjalainen, Antti
    Oksa, Panu
    Vainio, Harri
    Pukkala, Eero
    Brandt-Rauf, Paul W.
    BIOMARKERS, 2011, 16 (02) : 181 - 191
  • [50] Assessment of an immune response panel of serum protein biomarkers for the non-invasive detection of breast cancer
    McQuary, Philip R.
    Copeland, Karen A. F.
    Sheibani, Nadia M.
    Friedman, Lyssa A.
    Korn, Ronald L.
    Fiorica, James V.
    Lourenco, Ana P.
    Struthers, Sara E.
    Hesterberg, Lyndal K.
    CANCER RESEARCH, 2018, 78 (04)
12345